Egeland Ryan 4
4 · Cardiovascular Systems Inc · Filed Aug 24, 2020
Insider Transaction Report
Form 4
Egeland Ryan
Chief Medical Officer
Transactions
- Disposition to Issuer
Common Stock
[F1]2020-08-20−4,421→ 60,066 total - Tax Payment
Common Stock
[F2]2020-08-20$32.77/sh−3,223$105,618→ 57,443 total
Footnotes (2)
- [F1]Represents shares of performance-based restricted stock granted in November 2017 that have been forfeited based on the Company's three year total shareholder return for fiscal years 2018, 2019 and 2020 versus the Company's peer group.
- [F2]The reporting person has elected to satisfy his tax withholding obligation in connection with the vesting of a prior restricted stock grant by directing the Company to withhold shares otherwise issuable upon vesting of the previously reported grant.
Signature
/s/ Amanda Lorentz as Attorney-in-Fact for Ryan Egeland pursuant to Power of Attorney previously filed.|2020-08-24